The Bioavailability of Intranasal Salmon Calcitonin in Healthy Volunteers with and Without a Permeation Enhancer
- 1 January 1994
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 11 (5) , 747-750
- https://doi.org/10.1023/a:1018992716621
Abstract
Serum levels of radioimmunoactive salmon calcitonin (sCT) were determined in 10 healthy volunteers after intranasal administration (IN) of 100-, 205-, and 450-IU of sCT with 0.5% sodium...Keywords
This publication has 14 references indexed in Scilit:
- Biological Activity of Nasally Administered Insulin in Normal SubjectsHormone and Metabolic Research, 1990
- The effect of different doses of nasal salmon calcitonin on plasma cyclic AMP and serum ionized calciumCalcified Tissue International, 1990
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- Salmon Calcitonin in the Treatment of Postmenopausal OsteoporosisAnnals of Internal Medicine, 1987
- The effect of rectal and nasal administration of salmon calcitonin in normal subjectsCalcified Tissue International, 1987
- Salmon-calcitonin nasal spray in Paget's disease of bone: Preliminary results in five patientsCalcified Tissue International, 1985
- Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection.1985
- Long-term calcitonin therapy in postmenopausal osteoporosisMetabolism, 1984
- CalcitoninNew England Journal of Medicine, 1981
- Response of Paget's disease to porcine and salmon calcitonins: Effects of long-term treatmentThe American Journal of Medicine, 1974